Additional Local Therapy for Liver Metastases in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Systemic PSMA-Targeted Therapy

被引：18

作者：

Seifert, Robert ^{[1
]}

Kessel, Katharina ^{[1
]}

Boegemann, Martin ^{[2
]}

Koehler, Michael ^{[3
]}

Roll, Wolfgang ^{[1
]}

Stegger, Lars ^{[1
]}

Weckesser, Matthias ^{[1
]}

Rahbar, Kambiz ^{[1
]}

机构：

[1] Univ Hosp Munster, Dept Nucl Med, Albert Schweitzer Campus 1,Gebaude A1, D-48149 Munster, Germany

[2] Univ Hosp Munster, Dept Urol, Munster, Germany

[3] Univ Hosp Munster, Dept Clin Radiol, Munster, Germany

来源：

JOURNAL OF NUCLEAR MEDICINE | 2020年 / 61卷 / 05期

关键词：

PSMA; prostate cancer; SIRT; LU-177-PSMA-617 RADIOLIGAND THERAPY; SURVIVAL; CHEMOTHERAPY; GUIDELINE;

D O I：

10.2967/jnumed.119.233429

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

The aim of this study was to evaluate the efficacy of Lu-177-prostate-specific membrane antigen (PSMA)-617 (Lu-177-PSMA) and selective internal radiation therapy (SIRT) for the treatment of liver metastases of castration-resistant prostate cancer. Methods: Safety and survival of patients with metastatic castration-resistant prostate cancer and liver metastases assigned to Lu-177-PSMA alone (n = 31) or in combination with SIRT (n = 5) were retrospectively analyzed. Additionally, a subgroup (n = 10) was analyzed using morphologic and molecular response criteria. Results: Median estimated survival was 5.7 mo for Lu-177-PSMA alone and 8.4 mo for combined sequential Lu-177-PSMA and SIRT. Lu-177-PSMA achieved discordant therapy responses with both regressive and progressive liver metastases in the same patient (best vs. worst responding metastases per patient: -35% vs. +63% diameter change; P < 0.05). SIRT was superior to Lu-177-PSMA for the treatment of liver metastases (0% vs. 56% progression). Conclusion: The combination of Lu-177-PSMA and SIRT is efficient and feasible for the treatment of advanced prostate cancer. Lu-177-PSMA alone seems to have limited response rates in the treatment of liver metastases.

引用

页码：723 / 728

页数：6

共 22 条

[1] Overall survival and response pattern of castration-resistant metastatic prostate cancer to multiple cycles of radioligand therapy using [177Lu]Lu-PSMA-617 [J].

Ahmadzadehfar, Hojjat ;

Wegen, Simone ;

Yordanova, Anna ;

Fimmers, Rolf ;

Kuerpig, Stefan ;

Eppard, Elisabeth ;

Wei, Xiao ;

Schlenkhoff, Carl ;

Hauser, Stefan ;

Essler, Markus .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (09) :1448-1454

[2] Diffusion-weighted MRI Is Superior to PET/CT in Predicting Survival of Patients Undergoing 90Y Radioembolization of Hepatic Metastases [J].

Barabasch, Alexandra ;

Heinzel, Alexander ;

Bruners, Philipp ;

Kraemer, Nils A. ;

Kuhl, Christiane K. .

RADIOLOGY, 2018, 288 (03) :764-773

[3] The physics of radioembolization [J].

Bastiaannet, Remco ;

Kappadath, S. Cheenu ;

Kunnen, Britt ;

Braat, Arthur J. A. T. ;

Lam, Marnix G. E. H. ;

de Jong, Hugo W. A. M. .

EJNMMI PHYSICS, 2018, 5

[4] 177Lu-PSMA-617 radioligand therapy and outcome in patients with metastasized castration-resistant prostate cancer [J].

Braeuer, Axel ;

Grubert, Lena Sophie ;

Roll, Wolfgang ;

Schrader, Andres Jan ;

Schaefers, Michael ;

Boegemann, Martin ;

Rahbar, Kambiz .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (10) :1663-1670

[5] Dosimetry for 177Lu-DKFZ-PSMA-617: a new radiopharmaceutical for the treatment of metastatic prostate cancer [J].

Delker, Andreas ;

Fendler, Wolfgang Peter ;

Kratochwil, Clemens ;

Brunegraf, Anika ;

Gosewisch, Astrid ;

Gildehaus, Franz Josef ;

Tritschler, Stefan ;

Stief, Christian Georg ;

Kopka, Klaus ;

Haberkorn, Uwe ;

Bartenstein, Peter ;

Boening, Guido .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 (01) :42-51

[6] New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1) [J].

Eisenhauer, E. A. ;

Therasse, P. ;

Bogaerts, J. ;

Schwartz, L. H. ;

Sargent, D. ;

Ford, R. ;

Dancey, J. ;

Arbuck, S. ;

Gwyther, S. ;

Mooney, M. ;

Rubinstein, L. ;

Shankar, L. ;

Dodd, L. ;

Kaplan, R. ;

Lacombe, D. ;

Verweij, J. .

EUROPEAN JOURNAL OF CANCER, 2009, 45 (02) :228-247

[7] Validation of Several SUV-Based Parameters Derived from 18F-FDG PET for Prediction of Survival After SIRT of Hepatic Metastases from Colorectal Cancer [J].

Fendler, Wolfgang Peter ;

Tiega, Donfack Beauclair Philippe ;

Ilhan, Harun ;

Paprottka, Philipp M. ;

Heinemann, Volker ;

Jakobs, Tobias F. ;

Bartenstein, Peter ;

Hacker, Marcus ;

Haug, Alexander Robert .

JOURNAL OF NUCLEAR MEDICINE, 2013, 54 (08) :1202-1208

[8] EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds [J].

Giammarile, Francesco ;

Bodei, Lisa ;

Chiesa, Carlo ;

Flux, Glenn ;

Forrer, Flavio ;

Kraeber-Bodere, Francoise ;

Brans, Boudewijn ;

Lambert, Bieke ;

Konijnenberg, Mark ;

Borson-Chazot, Francoise ;

Tennvall, Jan ;

Luster, Markus .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 (07) :1393-1406

[9] Meta-Analysis Evaluating the Impact of Site of Metastasis on Overall Survival in Men With Castration-Resistant Prostate Cancer [J].

Halabi, Susan ;

Kelly, William Kevin ;

Ma, Hua ;

Zhou, Haojin ;

Solomon, Nicole C. ;

Fizazi, Karim ;

Tangen, Catherine M. ;

Rosenthal, Mark ;

Petrylak, Daniel P. ;

Hussain, Maha ;

Vogelzang, Nicholas J. ;

Thompson, Ian M. ;

Chi, Kim N. ;

de Bono, Johann ;

Armstrong, Andrew J. ;

Eisenberger, Mario A. ;

Fandi, Abderrahim ;

Li, Shaoyi ;

Araujo, John C. ;

Logothetis, Christopher J. ;

Quinn, David I. ;

Morris, Michael J. ;

Higano, Celestia S. ;

Tannock, Ian F. ;

Small, Eric J. .

JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (14) :1652-U191

[10] [177Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study [J].

Hofman, Michael S. ;

Violet, John ;

Hicks, Rodney J. ;

Ferdinandus, Justin ;

Thang, Sue Ping ;

Akhurst, Tim ;

Iravani, Amir ;

Kong, Grace ;

Kumar, Aravind Ravi ;

Murphy, Declan G. ;

Eu, Peter ;

Jackson, Price ;

Scalzo, Mark ;

Williams, Scott G. ;

Sandhu, Shahneen .

LANCET ONCOLOGY, 2018, 19 (06) :825-833

← 1 2 3 →